CONCORD DRUGS
Smallcap | BSE
Sector
Here's the live share price of Concord Drugs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.51₹ -1.22
As on Sep 11, 2026, 04:01 PM IST
Source: Dion Global
Concord Drugs Price Performance
Today's LowToday's High
₹78.26₹82.50
₹79.68
52 Weeks' Low52 Weeks' High
₹61.00₹92.52
₹79.68
Open Price
₹80.90
Prev. Close
₹80.90
Volume
5,836
Source: Dion Global
Concord Drugs Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Concord Drugs | -1.41 | 6.37 | 1.45 | 2.84 | 13.83 | 29.78 | 25.11 |
| Sun Pharmaceutical Industries | -3.00 | -5.05 | 2.66 | 0.94 | 14.44 | 17.44 | 18.75 |
| Divi's Laboratories | 2.48 | 9.24 | 40.21 | 46.89 | 55.09 | 35.68 | 12.89 |
| Torrent Pharmaceuticals | 2.58 | 2.20 | 8.86 | 12.32 | 38.96 | 38.62 | 26.07 |
| Zydus Lifesciences | -0.13 | -5.13 | 1.25 | 21.42 | 7.28 | 21.21 | 15.05 |
| Cipla | -1.44 | -6.63 | -1.30 | 2.64 | -12.55 | 3.07 | 7.51 |
| Laurus Labs | 7.08 | 5.93 | 41.70 | 89.43 | 120.18 | 69.19 | 24.99 |
| Aurobindo Pharma | 1.34 | 2.04 | 14.44 | 28.43 | 50.99 | 24.52 | 17.88 |
| Dr. Reddy's Laboratories | 0.61 | -3.65 | -8.94 | -12.41 | -10.93 | 1.13 | 3.31 |
| Lupin | -0.71 | -7.99 | -7.83 | -10.64 | 5.40 | 22.94 | 16.33 |
| Mankind Pharma | -2.21 | -6.10 | -3.99 | 1.50 | -12.31 | 8.80 | 9.84 |
| Glenmark Pharmaceuticals | -0.42 | 5.54 | 12.71 | 6.35 | 13.63 | 43.92 | 36.03 |
| Biocon | -1.59 | -9.08 | -6.20 | -1.11 | 7.45 | 12.25 | 2.03 |
| Alkem Laboratories | -1.97 | -7.63 | -4.00 | -8.04 | -5.70 | 11.91 | 5.85 |
| Abbott India | -1.93 | -8.71 | -1.93 | -6.03 | -17.45 | 3.61 | 3.60 |
| Anthem Biosciences | 0.44 | 5.18 | 20.27 | 44.65 | 14.34 | 8.70 | 5.13 |
| Ipca Laboratories | 0.10 | 12.45 | 21.95 | 28.38 | 49.90 | 29.83 | 8.68 |
| Gland Pharma | -0.08 | 0.20 | 27.09 | 75.91 | 49.07 | 20.30 | -5.12 |
| GlaxoSmithKline Pharmaceuticals | -4.34 | 8.98 | 34.59 | 13.88 | -1.18 | 24.68 | 12.96 |
| Ajanta Pharma | 2.10 | 0.96 | 12.64 | 16.15 | 37.46 | 26.89 | 19.98 |
Source: Dion Global
Over the last one year, Concord Drugs has gained 13.83% compared to peers like Sun Pharmaceutical Industries (14.44%), Divi's Laboratories (55.09%), Torrent Pharmaceuticals (38.96%). From a 5 year perspective, Concord Drugs has outperformed peers relative to Sun Pharmaceutical Industries (18.75%) and Divi's Laboratories (12.89%).
Concord Drugs Financials
Source: Dion Global
Concord Drugs Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 79.77 | 79.68 |
| 10 | 80.09 | 79.26 |
| 20 | 76.96 | 77.77 |
| 50 | 74.07 | 76.11 |
| 100 | 77.43 | 76.11 |
| 200 | 78.03 | 73.87 |
Source: Dion Global
Concord Drugs Share Holding Pattern
In the latest quarter, Concord Drugs saw a drop in promoter holding to 45.08%, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 54.91% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Concord Drugs Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 08, 2026, 01:03 AM IST IST | Concord Drugs - Letter To Shareholders |
| Sep 08, 2026, 12:58 AM IST IST | Concord Drugs - Intimation Of Record Date For 31St AGM |
| Sep 08, 2026, 12:53 AM IST IST | Concord Drugs - 31St AGM |
| Sep 08, 2026, 12:51 AM IST IST | Concord Drugs - Reg. 34 (1) Annual Report. |
| Sep 08, 2026, 12:45 AM IST IST | Concord Drugs - 31St Annual General Meeting |
Source: Dion Global
About Concord Drugs
Concord Drugs Ltd. is a Public Limited Listed company incorporated on 24/04/1995 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24230TG1995PLC020093 and registration number is 020093. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 75.85 Cr. and Equity Capital is Rs. 13.18 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- AddressSurvey No.249, R R District Telangana 501511
- Contact
Source: Dion Global
Management
- Mr. S Nagi ReddyChairman & Managing Director
- Mr. S Manoj Kumar ReddyWhole Time Director
- Mr. S Koni ReddyWholeTime Director & CFO
- Mr. K Ramachandra ReddyIndependent Director
- Ms. Sumeela KasuIndependent Director
- Mr. S Nagavenkata HareeshIndependent Director
FAQs on Concord Drugs Share Price
What is the share price of Concord Drugs?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Concord Drugs is ₹79.68 as on Sep 11, 2026.
What kind of stock is Concord Drugs?
The Concord Drugs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Concord Drugs?
The market cap of Concord Drugs is ₹104.98 Cr as on Sep 11, 2026.
What are today's High and Low prices of Concord Drugs?
Today’s highest and lowest price of Concord Drugs are ₹82.50 and ₹78.26.
What are the 52 Week High and 52 Week Low of Concord Drugs?
The 52-week high/low is the highest and lowest price at which Concord Drugs stock has traded in the past 52-week or nearly a year. The 52-week high of Concord Drugs is ₹92.52 and 52-week low of Concord Drugs is ₹61.00 as on Sep 11, 2026.
How has the Concord Drugs performed historically in terms of returns?
The Concord Drugs has shown returns of -1.51% over the past day, 6.37% for the past month, 1.45% over 3 months, 13.83% over 1 year, 29.78% across 3 years, and 25.11% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Concord Drugs?
P/E ratio of and PB ratio of Concord Drugs are 51.21 and 2.12 on Sep 11, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global
✕